Skip to main content
Clinical Trials/NCT03442049
NCT03442049
Completed
N/A

Randomized Controlled Trial of Core Stability Training in Patients With Multiple Sclerosis: Biomechanical and Performance Based Analysis of Gait

Hacettepe University0 sites68 target enrollmentJanuary 1, 2015

Overview

Phase
N/A
Intervention
Not specified
Conditions
Multiple Sclerosis
Sponsor
Hacettepe University
Enrollment
68
Primary Endpoint
6 Minutes Walk Test
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Gait and mobility are among the functions frequently affected in Multiple Sclerosis (MS) and have a negative impact on quality of life. Strength losses in lower limb muscles, ataxia, sensory problems and fatigue are the most important reasons of walking problems in patients with MS. In addition to loss of strength and tonus problems, especially biomechanical disorders can be seen on foot and this problem affects gatin and balance negatively. The stabilizing muscles, defined as the "core" region and enveloping the body like a corset, are active in the context of postural preparation prior to lower extremity movements and stabilize for the limb movements to be performed. The aim of this study was to investigate the effects of spinal stabilization exercises on walking performance, fatigue, plantar pressure distribution, balance, muscle strength and quality of life in patients with Multiple Sclerosis.

Registry
clinicaltrials.gov
Start Date
January 1, 2015
End Date
May 1, 2016
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Baris Cetin

Research Assisstant

Hacettepe University

Eligibility Criteria

Inclusion Criteria

  • Older than 18 years old
  • EDSS score is between 3-5,5
  • Patients who did not take corticosteroid therapy within three months
  • Patients who get at least 24 points from the Mini Mental Test were included in the study.

Exclusion Criteria

  • Patients who had an acute MS attack or had an attack within the last three months.
  • An orthopedic or systemic problem that would prevent participation in exercises
  • Patients who were using walking orthoses or walking aids were not included in the study.

Outcomes

Primary Outcomes

6 Minutes Walk Test

Time Frame: Change from Baseline 6 Minutes Walking Distance at 6 weeks.

Maximum Walking Distance in 6 Minutes

Plantar Pressure Distribution

Time Frame: Change from baseline peak pressure and contact area values at 6 weeks

Contact area values of 10 subregions under the foot

Modified Borg Scale

Time Frame: Change from Baseline Fatigue Score at 6 weeks.

Evaluating fatigue between the scores of 0 and 10. "0" means no fatigue at all. "10" means maximal fatigue.

Multiple Sclerosis Quality of Life Scale

Time Frame: Change from baseline mental and physical quality of life scores at 6 weeks

Quality of life assessment with 54 questions about mental and physical health in daily life activities.

Secondary Outcomes

  • Muscle strength with hand held dynamometer(Change from baseline muscle strength at 6 weeks)
  • MiniBESTest(Change from baseline MiniBESTest scores at 6 weeks)
  • Dynamic Gait Index(Change from baseline Dynamic Gait Index scores at 6 weeks)

Similar Trials